Comparison of DaTscan with 3T-MRI for parkinson syndrome: prospective study

Comparison of DaTscan with 3T-MRI for parkinson syndrome: prospective study - Comparison of DaTscan with 3T-MRI imaging for parkinson syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016186

Enrollment

Registered

2015-01-13

Start date

2015-01-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parkinson disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy control Patients who are suspected Parkinson disease and/or related disorders

Exclusion criteria

Exclusion criteria: 1. Patients who are severe hepatic and/or renal dysfunction 2. Patients who are past history of hypersensitivity to Alcohol 3. Patients who are taking medicine which affects the uptake of I-123-Ioflupane 4. Patients who have voiding dysfunction 5. Pregnant or woman of child-bearing potential 6. The woman under breast-feeding 7. Patients who were implanted metallic or electrical devices 8. Patients who are judged as inappropriate for inclusion by physicians

Design outcomes

Primary

Measure	Time frame
We evaluated the signal variation in substantia nigra by 3T-MRI and dopamine transporter by DaTscan. These are evaluated from the clinical severity of classification within three months.	—

Countries

Japan

Contacts

Public ContactYumiko Kono

Kansai Medical University Department of radiology

kohnoy@hirakata.kmu.ac.jp072-804-0101

Outcome results